Loss of major histocompatibility complex (MHC) class II gene expression predicts poor survival in diffuse large B celllymphoma (DLBCL)

被引：0
|
作者：
Rimsza, LM
LeBlanc, M
Braziel, R
Jaramillo, M
Miller, TP
Staudt, L
Grogan, TM
Fisher, R
机构：
[1] Univ Arizona, Tucson, AZ 85724 USA
[2] SW Oncol Grp, Seattle, WA USA
[3] Oregon Hlth Sci Univ, Portland, OR USA
[4] NIH, Bethesda, MD 20892 USA
[5] Univ Rochester, Rochester, NY 14642 USA
来源：
MODERN PATHOLOGY | 2003年 / 16卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1141
引用
收藏
页码：250A / 250A
页数：1
相关论文
共 50 条
  • [1] Loss of major histocompatibility complex (MHC) class II gene expression predicts poor survival in diffuse large B celllymphoma (DLBCL)
    Rimsza, LM
    LeBlanc, M
    Braziel, R
    Jaramillo, M
    Miller, TP
    Staudt, L
    Grogan, TM
    Fisher, R
    LABORATORY INVESTIGATION, 2003, 83 (01) : 250A - 250A
  • [2] Major histocompatibility complex (MHC) class II antigen HLA-DR gene expression levels in diffuse large B-cell lymphoma correlate with survival.
    Miller, TP
    LeBlanc, M
    Grogan, TM
    Braziel, RM
    Staudt, LM
    Fisher, RL
    BLOOD, 2002, 100 (11) : 346A - 346A
  • [3] Loss of major histocompatibility class II (MHCII) gene expression in diffuse large B cell lymphoma (DLBCL) is not generally due to genetic mutations in the coding regions of CIITA or RFX.
    Roberts, Robin A.
    Miller, Thomas P.
    Rimsza, Lisa M.
    BLOOD, 2006, 108 (11) : 577A - 578A
  • [4] Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival
    Roberts, Robin A.
    Wright, George
    Rosenwald, Andreas R.
    Jaramillo, Marina A.
    Grogan, Thomas M.
    Miller, Thomas P.
    Frutiger, Yvette
    Chan, Wing C.
    Gascoyne, Randy D.
    Ott, German
    Muller-Hermelink, Konrad
    Staudt, Louis M.
    Rimsza, Lisa M.
    BLOOD, 2006, 108 (01) : 311 - 318
  • [5] Loss of major histocompatibility class II (MHCII) expression in nodal diffuse large B cell lymphoma (DLBCL) is highly coordinated and unlikely related to chromosomal deletions.
    Rimsza, L
    Roberts, R
    Campo, E
    Grogan, T
    Bea, S
    Salaverria, I
    Zettl, A
    Fisher, R
    Unger, J
    LeBlanc, M
    Staudt, L
    Gascoyne, R
    Chan, W
    Weisenburger, D
    Greiner, T
    Jaffe, E
    Braziel, R
    Mueller-Hermelink, K
    BLOOD, 2003, 102 (11) : 893A - 893A
  • [6] EXPRESSION OF CLASS I AND CLASS II MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) ANTIGENS ON ISOLATED HEPATOCYTES
    LOBOYEO, A
    MIELIVERGANI, G
    MOWAT, AP
    VERGANI, D
    JOURNAL OF HEPATOLOGY, 1987, 5 : S161 - S161
  • [7] Expression of class II major complex histocompatibility in melanoma:: an indicator of poor prognosis
    Deshayes, F.
    Martins, I
    Sylla, K.
    Lauriol, J.
    Ghislain, S.
    Al-Daccak, R.
    Alcaide-Loridan, C.
    BULLETIN DU CANCER, 2007, 94 (06) : 548 - 548
  • [8] Major histocompatibility class II (MHCII) expression is lower in primary mediastinal B cell lymphoma (PMBCL) as compared to diffuse large B cell lymphoma (DLBCL) and correlates with patient survival.
    Rimsza, LM
    Roberts, RA
    Jaramillo, M
    Rosenwald, A
    Chan, WC
    Gascoyne, RD
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2005, 7 (05): : 667 - 667
  • [9] INTERFERON-INDUCED EXPRESSION OF CLASS-II MAJOR HISTOCOMPATIBILITY ANTIGENS IN THE MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS-II DEFICIENCY SYNDROME
    PLAEGERMARSHALL, S
    HAAS, A
    CLEMENT, LT
    GIORGI, JV
    CHEN, ISY
    QUAN, SG
    GATTI, RA
    STIEHM, ER
    JOURNAL OF CLINICAL IMMUNOLOGY, 1988, 8 (04) : 285 - 295
  • [10] Loss of major histocompatibility class II expression in diffuse large B-cell lymphoma may be related to stage of B-cell differentiation
    Wilkinson, Sarah T.
    Fernandez, Diane R.
    Vanpatten, Kristie A.
    Glinsmann-Gibson, Betty J.
    Grogan, Thomas M.
    Rimsza, Lisa M.
    CANCER RESEARCH, 2010, 70
12345